{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:13:36Z","timestamp":1788844416494,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05689-z","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T18:01:51Z","timestamp":1723744911000},"page":"3135-3140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeting complement dysregulation: eculizumab in scleroderma renal crisis management\u2014a case-based review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-7725","authenticated-orcid":false,"given":"Zeynep","family":"Toker Dincer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-7697","authenticated-orcid":false,"given":"Mevlut Tamer","family":"Dincer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5666-7723","authenticated-orcid":false,"given":"Gozde","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-2282","authenticated-orcid":false,"given":"Serdal","family":"Ugurlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-618X","authenticated-orcid":false,"given":"Nurhan","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4965-2918","authenticated-orcid":false,"given":"Emire","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"issue":"Suppl 6","key":"5689_CR1","doi-asserted-by":"publisher","first-page":"s58","DOI":"10.7861\/clinmedicine.15-6-s58","volume":"15","author":"CP Denton","year":"2015","unstructured":"Denton CP (2015) Advances in pathogenesis and treatment of systemic sclerosis. Clin Med 15(Suppl 6):s58\u2013s63. https:\/\/doi.org\/10.7861\/clinmedicine.15-6-s58","journal-title":"Clin Med"},{"issue":"4","key":"5689_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102494","volume":"19","author":"M Hughes","year":"2020","unstructured":"Hughes M, Pauling JD, Armstrong-James L, Denton CP, Galdas P, Flurey C (2020) Gender-related differences in systemic sclerosis. Autoimmun Rev 19(4):102494. https:\/\/doi.org\/10.1016\/j.autrev.2020.102494","journal-title":"Autoimmun Rev"},{"issue":"3","key":"5689_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/BOR.0000000000000604","volume":"31","author":"V Nagaraja","year":"2019","unstructured":"Nagaraja V (2019) Management of scleroderma renal crisis. Curr Opin Rheumatol 31(3):223\u2013230. https:\/\/doi.org\/10.1097\/BOR.0000000000000604","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"5689_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.autrev.2017.02.012","volume":"16","author":"S Hoa","year":"2017","unstructured":"Hoa S, Stern EP, Denton CP, Hudson M, Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working Group Investigators of the Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working Group (2017) Towards developing criteria for scleroderma renal crisis: a scoping review. Autoimmun Rev 16(4):407\u2013415. https:\/\/doi.org\/10.1016\/j.autrev.2017.02.012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"5689_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.semdp.2020.01.002","volume":"37","author":"AJ Gallan","year":"2020","unstructured":"Gallan AJ, Chang A (2020) A new paradigm for renal thrombotic microangiopathy. Semin Diagn Pathol 37(3):121\u2013126. https:\/\/doi.org\/10.1053\/j.semdp.2020.01.002","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"5689_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/2175-8239-JBN-3807","volume":"40","author":"R Zuckerman","year":"2018","unstructured":"Zuckerman R, Asif A, Costanzo EJ, Vachharajani T (2018) Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology. J Bras Nefrol 40(1):77\u201381. https:\/\/doi.org\/10.1590\/2175-8239-JBN-3807","journal-title":"J Bras Nefrol"},{"issue":"1","key":"5689_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","volume":"18","author":"M Okr\u00f3j","year":"2016","unstructured":"Okr\u00f3j M, Johansson M, Saxne T, Blom AM, Hesselstrand R (2016) Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis. Arthritis Res Ther 18(1):267. https:\/\/doi.org\/10.1186\/s13075-016-1168-x","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5689_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.tmrv.2019.09.004","volume":"33","author":"CJ Patriquin","year":"2019","unstructured":"Patriquin CJ, Kuo KHM (2019) Eculizumab and beyond: the past, present, and future of complement therapeutics. Transfus Med Rev 33(4):256\u2013265. https:\/\/doi.org\/10.1016\/j.tmrv.2019.09.004","journal-title":"Transfus Med Rev"},{"issue":"12","key":"5689_CR9","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/modpathol.2017.90","volume":"30","author":"JP Gaut","year":"2017","unstructured":"Gaut JP, Jain S, Pfeifer JD, Vigh-Conrad KA, Corliss M, Sharma MK, Heusel JW, Cottrell CE (2017) Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies. Mod Pathol 30(12):1739\u20131747. https:\/\/doi.org\/10.1038\/modpathol.2017.90","journal-title":"Mod Pathol"},{"issue":"11","key":"5689_CR10","first-page":"2218","volume":"34","author":"M Hudson","year":"2007","unstructured":"Hudson M, Walker JG, Fritzler M, Taillefer S, Baron M (2007) Hypocomplementemia in systemic sclerosis\u2014clinical and serological correlations. J Rheumatol 34(11):2218\u20132223","journal-title":"J Rheumatol"},{"key":"5689_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/543704","volume":"2010","author":"I Batal","year":"2010","unstructured":"Batal I, Domsic RT, Medsger TA, Bastacky S (2010) Scleroderma renal crisis: a pathology perspective. Int J Rheumatol 2010:543704. https:\/\/doi.org\/10.1155\/2010\/543704","journal-title":"Int J Rheumatol"},{"issue":"30","key":"5689_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004459","volume":"95","author":"A Devresse","year":"2016","unstructured":"Devresse A, Aydin S, Le Quintrec M, Demoulin N, Stordeur P, Lambert C, Gastoldi S, Pirson Y, Jadoul M, Morelle J (2016) Complement activation and effect of eculizumab in scleroderma renal crisis. Medicine 95(30):e4459. https:\/\/doi.org\/10.1097\/MD.0000000000004459","journal-title":"Medicine"},{"key":"5689_CR13","doi-asserted-by":"publisher","unstructured":"Hanna RM, Abdelnour L, Zuckerman JE, Ferrey AJ, Pai A, Vahabzadeh K, Wilson J, Torres EA, Kalantar-Zadeh K, Kurtz IB (2020) Refractory scleroderma renal crisis precipitated after high-dose oral corticosteroids and concurrent intravitreal injection of bevacizumab. SAGE Open Med Case Rep 8:2050313X20952650. https:\/\/doi.org\/10.1177\/2050313X20952650","DOI":"10.1177\/2050313X20952650"},{"issue":"6","key":"5689_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ckj\/sfv101","volume":"8","author":"CP Thomas","year":"2015","unstructured":"Thomas CP, Nester CM, Phan AC, Sharma M, Steele AL, Lenert PS (2015) Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome. Clin Kidney J 8(6):698\u2013701. https:\/\/doi.org\/10.1093\/ckj\/sfv101","journal-title":"Clin Kidney J"},{"issue":"2","key":"5689_CR15","doi-asserted-by":"publisher","first-page":"16385","DOI":"10.20452\/pamw.16385","volume":"133","author":"P Skonieczny","year":"2023","unstructured":"Skonieczny P, Wojteczek A, Zdrojewski Z, D\u0119bska-\u015alizie\u0144 A (2023) Atypical hemolytic-uremic syndrome due to scleroderma renal crisis treated with eculizumab. Pol Arch Intern Med 133(2):16385. https:\/\/doi.org\/10.20452\/pamw.16385","journal-title":"Pol Arch Intern Med"},{"issue":"2","key":"5689_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","volume":"36","author":"C Farmakidis","year":"2018","unstructured":"Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ (2018) Treatment of myasthenia gravis. Neurol Clin 36(2):311\u2013337. https:\/\/doi.org\/10.1016\/j.ncl.2018.01.011","journal-title":"Neurol Clin"},{"issue":"1","key":"5689_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ncl.2020.09.003","volume":"39","author":"AI Wallach","year":"2021","unstructured":"Wallach AI, Tremblay M, Kister I (2021) Advances in the treatment of neuromyelitis optica spectrum disorder. Neurol Clin 39(1):35\u201349. https:\/\/doi.org\/10.1016\/j.ncl.2020.09.003","journal-title":"Neurol Clin"},{"issue":"9","key":"5689_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.autrev.2018.03.012","volume":"17","author":"E Zanatta","year":"2018","unstructured":"Zanatta E, Polito P, Favaro M, Larosa M, Marson P, Cozzi F, Doria A (2018) Therapy of scleroderma renal crisis: state of the art. Autoimmun Rev 17(9):882\u2013889. https:\/\/doi.org\/10.1016\/j.autrev.2018.03.012","journal-title":"Autoimmun Rev"},{"key":"5689_CR19","doi-asserted-by":"publisher","first-page":"6051083","DOI":"10.1155\/2018\/6051083","volume":"2018","author":"MH Uriarte","year":"2018","unstructured":"Uriarte MH, Larrarte C, Rey LB (2018) Scleroderma renal crisis debute with thrombotic microangiopathy: a successful case treated with eculizumab. Case Rep Nephrol 2018:6051083. https:\/\/doi.org\/10.1155\/2018\/6051083","journal-title":"Case Rep Nephrol"},{"issue":"5 Pt 1","key":"5689_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.reuma.2018.03.008","volume":"16","author":"J Mart\u00ednez-Milla","year":"2020","unstructured":"Mart\u00ednez-Milla J, Gaebelt HP, S\u00e1nchez-Pernaute O, Kallmeyer A, Romero J, Farr\u00e9 J (2020) Scleroderma renal crisis: a reversible cause of left ventricular dysfunction. Reumatol Clin 16(5 Pt 1):359\u2013361. https:\/\/doi.org\/10.1016\/j.reuma.2018.03.008","journal-title":"Reumatol Clin"},{"issue":"11","key":"5689_CR21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31977","volume":"14","author":"L Saba","year":"2022","unstructured":"Saba L, Kassab J, Mehta V, Bari M (2022) Scleroderma renal crisis with thrombotic microangiopathy treated with eculizumab. Cureus 14(11):e31977. https:\/\/doi.org\/10.7759\/cureus.31977","journal-title":"Cureus"},{"key":"5689_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.rmcr.2018.08.010","volume":"25","author":"H Bukamur","year":"2018","unstructured":"Bukamur H, Aqtash O, Shahoub I, Karem E, Ogu I, Zeid F (2018) Atypical rapid onset scleroderma renal crisis (SRC) complicated with diffuse alveolar hemorrhage and pleuro-pericardial effusions in a patient with recently diagnosed breast cancer and a positive anti-RNA polymerase III Ab.: a case report. Respir Med Case Rep 25:137\u2013141. https:\/\/doi.org\/10.1016\/j.rmcr.2018.08.010","journal-title":"Respir Med Case Rep"},{"key":"5689_CR23","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.936116","volume":"23","author":"M Nakamura","year":"2022","unstructured":"Nakamura M, Abe T, Ochiai H (2022) Thrombotic microangiopathy secondary to systemic sclerosis with severe complement activation not responsive to eculizumab: a case report. Am J Case Rep 23:e936116. https:\/\/doi.org\/10.12659\/AJCR.936116","journal-title":"Am J Case Rep"},{"issue":"3","key":"5689_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/ndt\/gfw453","volume":"32","author":"T Cavero","year":"2017","unstructured":"Cavero T, Rabasco C, L\u00f3pez A, Rom\u00e1n E, \u00c1vila A, Sevillano \u00c1, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, Garc\u00eda A, Mendizabal S, Gavela E, Mac\u00eda M, Quintana LF, Mar\u00eda Romera A, Borrego J, Arjona E, Espinosa M et al (2017) Eculizumab in secondary atypical haemolytic uraemic syndrome. Nephrol Dial Transplant 32(3):466\u2013474. https:\/\/doi.org\/10.1093\/ndt\/gfw453","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"5689_CR25","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ekir.2021.01.021","volume":"6","author":"A Gouin","year":"2021","unstructured":"Gouin A, Ribes D, Colombat M, Chauveau D, Prevot G, Lairez O, Pugnet G, Fremeaux-Bacchi V, Huart A, Belliere J, Faguer S (2021) Role of C5 inhibition in idiopathic inflammatory myopathies and scleroderma renal crisis-induced thrombotic microangiopathies. Kidney Int Rep 6(4):1015\u20131021. https:\/\/doi.org\/10.1016\/j.ekir.2021.01.021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"5689_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100753","volume":"6","author":"C Trivin-Avillach","year":"2023","unstructured":"Trivin-Avillach C, Jaberi A, Henderson JM, Beck LH Jr, Francis J (2023) Eculizumab use in scleroderma renal crisis with thrombotic microangiopathy: a case report. Kidney Med 6(1):100753. https:\/\/doi.org\/10.1016\/j.xkme.2023.100753","journal-title":"Kidney Med"},{"issue":"8S","key":"5689_CR27","doi-asserted-by":"publisher","first-page":"S355","DOI":"10.1097\/RHU.0000000000001579","volume":"27","author":"LC Arneson","year":"2021","unstructured":"Arneson LC, Varga J (2021) Scleroderma renal crisis complicating male-to-female transgender hormonal therapy in a patient with long-standing and stable limited cutaneous systemic sclerosis. J Clin Rheumatol 27(8S):S355\u2013S356. https:\/\/doi.org\/10.1097\/RHU.0000000000001579","journal-title":"J Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05689-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T16:04:56Z","timestamp":1733328296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05689-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5689"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05689-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript has not been prepared with the assistance of professional editing agencies or AI-based editing software.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Editing and AI disclaimer"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}